REFERENCES
- White L, Tursky B, Schwartz G E. Placebo: Theory, research, and mechanisms. Guilford Press, New York 1985
- Kaptchuk T J. Intentional ignorance: A history of blind assessment and placebo controls in medicine. Bull Hist Med 1998; 72: 389–433
- Schulz K F, Chalmers I, Hayes R J, Altman D G. Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials. JAMA 1995; 273: 408–412
- Kintz B L, Delprato D J, Mettee D R, Persons C E, Schappe R H. The experimenter effect. Psychol Bull 1965; 63: 223–232
- McRae C, Cherin E, Yamazaki T G, et al. Effects of perceived treatment on quality of life and medical outcomes in a double-blind placebo surgery trial. Arch Gen Psychiatry 2004; 61: 412–420
- Bausell R B, Lao L, Bergman S, Lee W L, Berman B M. Is acupuncture analgesia an expectancy effect? Preliminary evidence based on participants' perceived assignments in two placebo-controlled trials. Eval Health Prof 2005; 28: 9–26
- Rabkin J G, Markowitz J S, Stewart J, et al. How blind is blind? Assessment of patient and doctor medication guesses in a placebo-controlled trial of imipramine and phenelzine. Psychiatry Res 1986; 19: 75–86
- Hughes J R, Krahn D. Blindness and the validity of the double-blind procedure. J Clin Psychopharmacol 1985; 5: 138–142
- Fergusson D, Glass K C, Waring D, Shapiro S. Turning a blind eye: The success of blinding reported in a random sample of randomised, placebo controlled trials. BMJ 2004; 328: 432
- Fisher S, Greenberg R P. How sound is the double-blind design for evaluating psychotropic drugs?. J Nerv Ment Dis 1993; 181: 345–350
- Perkins K A, DiMarco A, Grobe J E, Scierka A, Stiller R L. Nicotine discrimination in male and female smokers. Psychopharmacol 1994; 116: 407–413
- Fishman J, Reynolds T, Riedel E. A retrospective investigation of an intensive outpatient substance abuse treatment program. Am J Drug Alcohol Abuse 1999; 25: 185–196
- Schulz K F, Grimes D A. Blinding in randomized trials: Hiding who got what. Lancet 2002; 359: 696–700
- Wickizer T, Maynard C, Atherly A, et al. Completion rates of clients discharged from drug and alcohol treatment programs in Washington State. Am J Public Health 1994; 84: 215–221
- Kampman K M, Dackis C, Lynch K G, et al. A double-blind, placebo-controlled trial of amantadine, propranolol, and their combination for the treatment of cocaine dependence in patients with severe cocaine withdrawal symptoms. Drug Alcohol Depend 2006; 85: 129–137
- Chick J, Anton R, Checinski K, et al. A multicentre randomized, double-blind, placebo-controlled trial of naltrexone in the treatment of alcohol dependence or abuse. Alcohol Alcohol 2000; 35: 587–593
- Bosworth H B. Medication treatment adherence. Patient Treatment Adherence: Concepts, Interventions and Measurements, H B Bosworth, E Z Oddone, M Weinberger. Lawrence Erlbaum Associates, Mahwah, NJ 2006; 158
- Landis J R, Koch G G. An application of hierarchical kappa-type statistics in the assessment of majority agreement among multiple observers. Biometrics 1977; 33: 363–374
- Fleiss J L. Statistical Methods for Rates and Proportions, 2nd ed. Wiley Interscience, New York 1981